neurocognitive disorders including dementia - Alzheimer's

The Regional Geriatric Program of Eastern Ontario is pleased to announce that their annual Geriatric Refresher Day is focused on a variety of topics related to dementia. This is event will be held virtually over two days: June 15th and June 22nd from 8:00 am - 12:30. Cost is 75$

Audience: clinicians working with people living with dementia

\This webinar will describe a nurse mentoring program initiated by Dr Philippe Voyer at the Centre d'excellence sur le vieillissement de Québec. Three studies will be presented, which evaluated the effects of the mentoring program on non-pharmacological interventions for behavioural and psychological symptoms of dementia (BPSD) among seniors in long-term care.

A complementary study focusing on nurse-pharmacist collaboration in long-term care settings, and its results regarding the use of antipsychotics for BPSD will also be presented.

No new medication for Alzheimer Disease and dementia  (other than treatments for the behavioural problems) has been approved in Canada in twenty years. We will review where we are now - medications with modest effects for cognitive symptoms and behavioural and psychological problems. We will look at where we want to be with curative and preventative treatments, and examine how we may get to those goals in the next decade.

The Dementia Isolation Toolkit was developed to support residents of long-term care during periods of isolation, as well as to address moral distress in long-term care home staff.  In this presentation, we will speak about how this tool has been used during the pandemic, barriers and facilitators to its use, and some preliminary research on its impact.

This presentation will review clinical features of behavioral variant frontotemporal (bvFTD) dementia. We will focus on the complexities of differentiating primary psychiatric disorders from frontotemporal dementia (FTD) in the clinical context. We will discuss recent developments in diagnostic approaches and tests for FTD, and how those can be integrated in clinical practice.

In response to the COVID-19 pandemic, many health care services moved to virtual delivery. Given this unprecedented increase in virtual care, it is important to consider the potential impact on quality and access to care for different patient groups, including adults with intellectual and developmental disabilities.

Researchers in Ontario conducted a study to find out what is already known about virtual health care for adults with intellectual and developmental disabilities and, in particular, the impact of virtual delivery on access to care for this population.

The care of people with dementia is a WHO public health priority. People with dementia use health services twice as much as people without dementia. Interdisciplinary primary care such as family practice groups and continuity of care with the family physician have been proposed as an ideal approach to managing the growing and complex population of people with dementia, but evidence of their effect is lacking, particularly in terms of equity of access to services.

WEBINAR DESCRIPTION
Dementia is a general term referring to a variety of brain disorders. By understanding the reasons for the changes in behaviour of a person living with dementia, caregivers can improve their skills to support and help the person to live well with dementia. The 8 A’s of dementia give us clues to understand the meaning behind the behaviours and the brain changes that contribute to them.

Direct registration link: https://is.gd/JanuaryTERLA1

The COVID-19 pandemic has been especially hard on marginalized groups, such as people with intellectual and developmental disabilities (IDDs) like Down syndrome or autism.

For people with IDDs, stressors include the abrupt stop to daily routines and regular contact with friends and family, restricted availability of health services and paid support, and financial difficulties. These stressors are compounded by the challenges people with IDDs face in understanding infection risks and public health restrictions.

The onset of dementia can have a devastating impact on an individual’s identity. See how culturally based and linguistically accessible programming and interventions help to reclaim and preserve one’s identity and dignity.

Date: Friday December 3, 2021

Time: 1:00 - 2:30 p.m.

Best practices when providing language support in services for older adults requires special considerations and strategies.  Language access in this context can be made more complex by multiple factors such as mental health, age-related speech and/or hearing loss, family involvement and intervention, and cognitive impairment.  A deeper understanding of these dynamics can optimize the outcomes in interpreter-assisted appointments.

Learning objectives:

Stigma of dementia is one of the greatest issues for people with dementia and their care partners. It can lead to depression, low self-esteem, social isolation, and a decreased quality of life. Research shows that people fear dementia more than stroke, cancer, and heart disease combined. Despite this knowledge, few studies focus on actions to address stigma of dementia.  

Please join us on Thursday, November 4th, 2021 from 2pm - 3pm ET for the Understanding Dementia in Later Life Workshop. This free workshop is for older adults (65+) and their caregivers.

After the workshop you will receive resources available in English, French, Spanish, Italian, Traditional Chinese, Simplified Chinese and Punjabi.

Half of Canadians will have a hearing loss by 75 years of age. Hearing loss increases the risk of cognitive decline and dementia. Those with combined hearing loss and cognitive impairment are at increased risk for declines in everyday functioning and entry into long-term care. Importantly, hearing loss is the largest potentially modifiable risk factor for dementia. This presentation will describe the connections between hearing loss and cognitive decline, with an emphasis on what could be done to help reduce the risk of dementia and optimize everyday functioning and care.

There is widespread skepticism about the rationale for an early diagnosis of dementia and the efficacy and effectiveness of treatment interventions. A new case of Dementia arises in the world every three seconds but how many get a diagnosis let alone an effective treatment. With the global economic cost of more than 800 Billion USD, there is a very strong case for an early diagnosis which surely has multiple recognized benefits both to the individual, families and the world at large but the challenge is how to do it.